公司資料
Better Therapeutics 股價、新聞與催化劑
- 股票代碼:
- BTTX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
Current closing-price context is not available for BTTX.
公司概覽
業務概覽
Better Therapeutics was a digital therapeutics company focused on behavior-change software for cardiometabolic disease. The company tried to turn prescription-grade software into a chronic-care treatment option, but its identity was always tied to the difficult economics of digital health.
所在地與產業分類
Better Therapeutics was headquartered in the United States and listed on NASDAQ. It sat in digital health rather than classic biotechnology, with a product profile centered on software-delivered care.
商業模式特徵
The business depended on payer adoption, clinical validation, and the ability to show that software could meaningfully change chronic-disease outcomes. Investors watched commercialization progress, reimbursement, and platform credibility more than clinical trial binaries.
生技產業定位
Better Therapeutics occupied a small digital-therapeutics niche within healthcare innovation. Compared with drug developers, its valuation was more sensitive to commercial traction and payer access than to FDA-drug milestones.
未來催化劑
- Better Therapeutics is largely a legacy / closeout story now, so the catalysts are any strategic or asset-resolution update rather than a new product cycle. The market is focused on what remains after the digital-therapy unwind.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。